HC devotees of Noxopharm know more about NOX than stockbrokers, in my opinion, and yet we have missed a major story. Nyrada today announced stunning pre-clinical results for its oral cholesterol drug, in a mouse model that is known to predict response in humans, suggesting that NYX-PCSK9i is potentially better that the best-selling drug of all time. Noxopharm owns about 30% of Nyrada.
See: showdownloaddoc.aspx (nyrada.com)
But we did not miss everything. For instance, we knew about the Notice of Allowance in Europe that was announced today, but we also know that a couple of patent grants are looking particularly good in the USA; and we also know that a Notice of Allowance was issued in the USA for Nyrada's cholesterol drug on 6 April 2021. The stagnant share price of Nyrada suggests that the Market has not made this connection.
Nyrada is a hidden gem, in my view, as is Pharmorage.
- Forums
- ASX - By Stock
- Hidden Gems
HC devotees of Noxopharm know more about NOX than stockbrokers,...
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
6.8¢ |
Change
-0.001(1.45%) |
Mkt cap ! $19.87M |
Open | High | Low | Value | Volume |
6.8¢ | 6.8¢ | 6.6¢ | $10.20K | 152.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 51263 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 59000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 51263 | 0.067 |
2 | 86092 | 0.066 |
1 | 100000 | 0.064 |
3 | 47786 | 0.061 |
4 | 105033 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 59000 | 1 |
0.070 | 1000 | 1 |
0.073 | 1000 | 1 |
0.079 | 12000 | 2 |
0.080 | 12099 | 2 |
Last trade - 12.52pm 27/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |